129 related articles for article (PubMed ID: 38385164)
1. The discovery of a novel IκB kinase β inhibitor based on pharmacophore modeling, virtual screening and biological evaluation.
Li L; Gong S
Future Med Chem; 2024 Mar; 16(6):531-544. PubMed ID: 38385164
[TBL] [Abstract][Full Text] [Related]
2. IKKβ inhibitor identification: a multi-filter driven novel scaffold.
Nagarajan S; Choo H; Cho YS; Shin KJ; Oh KS; Lee BH; Pae AN
BMC Bioinformatics; 2010 Oct; 11 Suppl 7(Suppl 7):S15. PubMed ID: 21106122
[TBL] [Abstract][Full Text] [Related]
3. Hit identification of IKKβ natural product inhibitor.
Leung CH; Chan DS; Li YW; Fong WF; Ma DL
BMC Pharmacol Toxicol; 2013 Jan; 14():3. PubMed ID: 23294515
[TBL] [Abstract][Full Text] [Related]
4. Combination of pharmacophore model development and binding mode analyses: identification of ligand features essential for IκB kinase-beta (IKKβ) inhibitors and virtual screening based on it.
Sun HP; Zhu J; Chen FH; Zhang SL; Zhang Y; You QD
Eur J Med Chem; 2011 Sep; 46(9):3942-52. PubMed ID: 21708416
[TBL] [Abstract][Full Text] [Related]
5. Pentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro Evidences.
Patil KR; Mohapatra P; Patel HM; Goyal SN; Ojha S; Kundu CN; Patil CR
PLoS One; 2015; 10(5):e0125709. PubMed ID: 25938234
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of novel
Xie X; Tu J; You H; Hu B
Drug Des Devel Ther; 2017; 11():1439-1451. PubMed ID: 28553074
[TBL] [Abstract][Full Text] [Related]
7. 3D QSAR pharmacophore model based on diverse IKKβ inhibitors.
Nagarajan S; Ahmed A; Choo H; Cho YS; Oh KS; Lee BH; Shin KJ; Pae AN
J Mol Model; 2011 Feb; 17(2):209-18. PubMed ID: 20419497
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
9. Novel IKKβ inhibitors discovery based on the co-crystal structure by using binding-conformation-based and ligand-based method.
Huang JJ; Wu XW; Jia JM; Guo XK; Xue X; Jiang ZY; Zhang SL; Zhang XJ; Sun HP; You QD
Eur J Med Chem; 2013 May; 63():269-78. PubMed ID: 23501112
[TBL] [Abstract][Full Text] [Related]
10. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening.
Nagarajan S; Doddareddy Mr; Choo H; Cho YS; Oh KS; Lee BH; Pae AN
Bioorg Med Chem; 2009 Apr; 17(7):2759-66. PubMed ID: 19285872
[TBL] [Abstract][Full Text] [Related]
11. A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells.
Wen D; Nong Y; Morgan JG; Gangurde P; Bielecki A; Dasilva J; Keaveney M; Cheng H; Fraser C; Schopf L; Hepperle M; Harriman G; Jaffee BD; Ocain TD; Xu Y
J Pharmacol Exp Ther; 2006 Jun; 317(3):989-1001. PubMed ID: 16525037
[TBL] [Abstract][Full Text] [Related]
12. Novel non-peptide small molecules preventing IKKβ/NEMO association inhibit NF-κB activation in LPS-stimulated J774 macrophages.
De Falco F; Di Giovanni C; Cerchia C; De Stefano D; Capuozzo A; Irace C; Iuvone T; Santamaria R; Carnuccio R; Lavecchia A
Biochem Pharmacol; 2016 Mar; 104():83-94. PubMed ID: 26776306
[TBL] [Abstract][Full Text] [Related]
13. Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.
Zhang Y; Lapidus RG; Liu P; Choi EY; Adediran S; Hussain A; Wang X; Liu X; Dan HC
Mol Cancer Ther; 2016 Jul; 15(7):1504-14. PubMed ID: 27196761
[TBL] [Abstract][Full Text] [Related]
14. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
[TBL] [Abstract][Full Text] [Related]
15. IKKbeta inhibitors identification part II: ligand and structure-based virtual screening.
Nagarajan S; Choo H; Cho YS; Oh KS; Lee BH; Shin KJ; Pae AN
Bioorg Med Chem; 2010 Jun; 18(11):3951-60. PubMed ID: 20488717
[TBL] [Abstract][Full Text] [Related]
16. Discovery of potent and selective rhodanine type IKKβ inhibitors by hit-to-lead strategy.
Song H; Lee YS; Roh EJ; Seo JH; Oh KS; Lee BH; Han H; Shin KJ
Bioorg Med Chem Lett; 2012 Sep; 22(17):5668-74. PubMed ID: 22858099
[TBL] [Abstract][Full Text] [Related]
17. A novel inhibitor of I-kappaB kinase beta ameliorates experimental arthritis through downregulation of proinflammatory cytokines in arthritic joints.
Tanaka S; Toki T; Yokoyama M; Shimizu H; Yamasaki T; Yoneda Y; Muro F; Yasukochi T; Iimura S; Morishita K
Biol Pharm Bull; 2014; 37(1):87-95. PubMed ID: 24389485
[TBL] [Abstract][Full Text] [Related]
18. Rabdosichuanin C inhibits productions of pro-inflammatory mediators regulated by NF-κB signaling in LPS-stimulated RAW264.7 cells.
Lingxia Z; Hong W; Man G; Xinzhou W; Lili W; Zhimin W; Liping D; Erping X
J Cell Biochem; 2023 Nov; 124(11):1667-1684. PubMed ID: 37850620
[TBL] [Abstract][Full Text] [Related]
19. The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway.
Tian F; Zhou P; Kang W; Luo L; Fan X; Yan J; Liang H
J Recept Signal Transduct Res; 2015; 35(4):307-18. PubMed ID: 25386663
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitors of IκB kinase β: A chip-based screening and molecular docking simulation.
Cho YW; Lim HJ; Han MH; Kim BC; Han S
Bioorg Med Chem; 2020 May; 28(9):115440. PubMed ID: 32205046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
